ATE318609T1 - Phaseolamin-zusammensetzungen und verfahren zur anwendung derselben - Google Patents

Phaseolamin-zusammensetzungen und verfahren zur anwendung derselben

Info

Publication number
ATE318609T1
ATE318609T1 AT02078977T AT02078977T ATE318609T1 AT E318609 T1 ATE318609 T1 AT E318609T1 AT 02078977 T AT02078977 T AT 02078977T AT 02078977 T AT02078977 T AT 02078977T AT E318609 T1 ATE318609 T1 AT E318609T1
Authority
AT
Austria
Prior art keywords
methods
compositions
phaseolamine
same
mineral
Prior art date
Application number
AT02078977T
Other languages
English (en)
Inventor
Dilip Chokshi
Original Assignee
Pharmachem Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachem Lab Inc filed Critical Pharmachem Lab Inc
Application granted granted Critical
Publication of ATE318609T1 publication Critical patent/ATE318609T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/06—Products with modified nutritive value, e.g. with modified starch content
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/02—Treatment of flour or dough by adding materials thereto before or during baking by adding inorganic substances
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A21D2/266—Vegetable proteins from leguminous or other vegetable seeds; from press-cake or oil bearing seeds
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/267—Microbial proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A21D2/368—Fermentation by-products, e.g. grapes, hops
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AT02078977T 2001-09-25 2002-09-25 Phaseolamin-zusammensetzungen und verfahren zur anwendung derselben ATE318609T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/962,917 US6797287B2 (en) 2001-09-25 2001-09-25 Phaseolamin compositions and methods for using the same

Publications (1)

Publication Number Publication Date
ATE318609T1 true ATE318609T1 (de) 2006-03-15

Family

ID=25506500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02078977T ATE318609T1 (de) 2001-09-25 2002-09-25 Phaseolamin-zusammensetzungen und verfahren zur anwendung derselben

Country Status (7)

Country Link
US (3) US6797287B2 (de)
EP (2) EP1618801A1 (de)
AT (1) ATE318609T1 (de)
CA (1) CA2390215C (de)
DE (1) DE60209442T2 (de)
ES (1) ES2259360T3 (de)
HK (1) HK1054299B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2490079A1 (en) * 2002-06-28 2004-01-08 Pharmachem Laboratories, Inc. Purified amylase inhibitor and novel process for obtaining the same
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
ITMI20030391A1 (it) * 2003-03-04 2004-09-05 S I I T S R L Servizio Internaz Ionale Imballa Formulazioni anticarie a base di faseolamina.
US20050003027A1 (en) * 2003-05-09 2005-01-06 Diaz Jose A. Chemical composition and method to bind fat, enhance metabolization, and aid digestion
PL209905B1 (pl) * 2004-01-15 2011-11-30 Bringwell Internat Ab Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
ITMI20040313A1 (it) * 2004-02-24 2004-05-24 S I I T S R L Servizio Interna Formulazioni gastroprotette di inbitori di enzimi ad attivita' alfa-amilasica
ITMI20040619A1 (it) * 2004-03-30 2004-06-30 Consiglio Nazionale Ricerche Estratto purificato di inibitore dell'alfa-amilasi da fagioli essenzialmente privi di fitoemoagglutinina procedimento di estrazione e composizioni che lo contengono
US20050238638A1 (en) * 2004-04-21 2005-10-27 Jonathan Gutwein Dietary Supplement that Serves as a Carbohydrate Blocker and Hangover Remedy
US7476406B1 (en) * 2004-05-17 2009-01-13 Nse Products, Inc. Multifaceted weight control system
US7588759B2 (en) * 2004-12-17 2009-09-15 Avoca, Inc. Compositions comprising sclareol or derivatives thereof and uses thereof
US20060257332A1 (en) * 2005-05-13 2006-11-16 Pierro Francesco D Anticaries compositions containing phaseolamin
FR2892894B1 (fr) * 2005-11-08 2008-01-11 Juva Soc Par Actions Simplifie Complement alimentaire comprenant de la phaseolamine.
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
ITMI20052451A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
EP1923067B1 (de) * 2006-11-20 2016-04-13 S.I.I.T. S.r.l.-Servizio Internazionale Imballaggi Termosaldanti Zusammensetzungen, die Extrakte von Phaseolus vulgaris und Alpinia officinarum enthalten, zur Prävention und Behandlung von Fettleibigkeit und Typ II Diabetes
EP1967200A1 (de) * 2007-03-07 2008-09-10 Indena S.P.A. Formulierungen aus Alpha-Amylase-Hemmern von P. vulgaris mit Alpha-Glucosidase-Hemmern von S. oblonga oder S. reticulata zur Behandlung von Diabetes und Adipositas
US7940861B2 (en) * 2007-12-07 2011-05-10 Advantech Advanced Microwave Technologies, Inc. QAM phase error detector
FR2934468A1 (fr) * 2008-07-31 2010-02-05 Christian Fenioux Composition stabilisee a base d'extrait de haricot diminuant notamment l'index glycemique des produits alimentaires a base d'amidon et permettant un meilleur controle du poids.
US20100040732A1 (en) * 2008-08-18 2010-02-18 Vdf Futureceuticals, Inc. Compositions and Methods for Fermented Nutraceuticals
TWI522109B (zh) * 2009-01-26 2016-02-21 臺北醫學大學 蕨素化合物用於治療糖尿病及肥胖之用途
GB2507254A (en) * 2012-09-13 2014-04-30 Ajit Ramanial Patel Composition for reducing the consumption of food and the absorption of carbohydrate constituents thereof
WO2018175417A1 (en) * 2017-03-21 2018-09-27 Pharmachem Laboratories, Llc Controlled release of phaseolamin compositions
CN108576735B (zh) * 2018-05-09 2022-03-15 北京市农林科学院 一种具有抑制淀粉分解作用的果冻及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE151869C (de)
DE2628757A1 (de) 1976-06-26 1977-12-29 Guenter Dr Woeber Amylase inhibitor
DD151869A1 (de) * 1980-07-09 1981-11-11 Joachim Doerfer Verfahren zur inhibierung der alpha-amylaseaktivitaet bei der backwarenherstellung aus enzymreichen mehlen
JPH0393800A (ja) * 1989-09-05 1991-04-18 Sumitomo Chem Co Ltd インゲンマメ種子から抽出したアズキゾウムシ等の幼虫の生育阻害物質
US5612039A (en) 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
JP2002535288A (ja) 1999-01-22 2002-10-22 ウンツァ ディ マリア カルメラ マラッツィータ エッセ．ア．エッセ． リポタンパク質複合体およびそれらを含む組成物
GB9921229D0 (en) 1999-09-08 1999-11-10 Med Eq As Compositions

Also Published As

Publication number Publication date
US20050152952A1 (en) 2005-07-14
US7049288B2 (en) 2006-05-23
US20030059457A1 (en) 2003-03-27
EP1295535A2 (de) 2003-03-26
EP1295535A3 (de) 2003-07-09
DE60209442T2 (de) 2006-10-12
EP1295535B1 (de) 2006-03-01
HK1054299B (zh) 2006-05-26
CA2390215C (en) 2010-12-07
ES2259360T3 (es) 2006-10-01
US6797287B2 (en) 2004-09-28
HK1054299A1 (en) 2003-11-28
CA2390215A1 (en) 2003-03-25
DE60209442D1 (de) 2006-04-27
EP1618801A1 (de) 2006-01-25
US20030059403A1 (en) 2003-03-27
US6900174B2 (en) 2005-05-31

Similar Documents

Publication Publication Date Title
DE60209442D1 (de) Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselben
MX2007006104A (es) Metodos para purificar trans-(-)-?9-tetrahidrocanabinol y trans-(+)-?9-tetrahidrocanabinol.
UA94913C2 (ru) Применение эритропоэтина для лечения сахарного диабета
ATE385419T1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
BRPI0519593A2 (pt) composto, mÉtodos de tratar distérbios neurodegenerativos e complicaÇÕes devido a derrame ou trauma na cabeÇa, e de preparar um composto, e, uso de um composto
HK1084404A1 (en) Muteins of tear lipocalin
DE60330757D1 (de) Verwendung von pyridylamiden als angiogenesehemmer
WO2005037199A3 (en) Pyrazole derivatives as cannabinoid receptor modulators
EP2371389A3 (de) FC-Gamma-RIIB-spezifische Antikörper und Verwendungsverfahren davon
BR0208142A (pt) Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
BR0212968A (pt) Composição farmacêutica, composto, e, método para tratar ou prevenir condições mediadas pelo ccr2, mcp-1 ou pela interação destes
BR0214884A (pt) Derivados de 7-amino-benzotiazol como ligantes do receptor de adenosina
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
AU2003218110A1 (en) C3-cyano epothilone derivatives
BR9916680A (pt) Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina
DK1096865T3 (da) Antimikrobiel sammensætning
DE60230961D1 (de) Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
BR0213317A (pt) Uso de um composto, método de tratar um distúrbio relacionado com gastrina, composição farmacêutica, kit, usos de uma composição, e de um inibidor de bomba de próton, métodos de preparar uma composição farmacêutica e um composto, e, composto
BR0311223A (pt) Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c
BR9916537A (pt) Composição de fragrância, produto, uso de camonal, ciprisato, elintaal e/ou dispirona, e, processo para aumentar as propriedades de redução do malodor de uma composição de fragrância
DE69402441D1 (de) Neue 17,20-Epoxyd Derivate von Pregnan, ihre Verwendung zur Herstellung von Cortison-Derivaten und Zwischenprodukte dafür
ATE334977T1 (de) Discodermolid-analoga und ihre pharmazeutische verwendung
AU7287891A (en) Novel ascorbic acid derivatives
WO2002098454A3 (en) Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties